IPOT was up 6.5% today , mc $23.93 M trading over 3X average volume
limited supply being that isracann is the first ever pure-play cannabis firm in Israel - and enormous demand considering the country has the highest highest cannabis use per capita in the world. (~27%)
The underserved domestic market presents significant and immediate opportunity for $IPOT
Israel has all around optimal climatic conditions from humidity, temperature and sunlight, to organically grow medical cannabis with the lowest possible production costs.
EU medical market estimated to be $64B USD by 2028.
IPOT was up 6.5% today , mc $23.93 M trading over 3X average volume
limited supply being that isracann is the first ever pure-play cannabis firm in Israel - and enormous demand considering the country has the highest highest cannabis use per capita in the world. (~27%)
The underserved domestic market presents significant and immediate opportunity for $IPOT
Israel has all around optimal climatic conditions from humidity, temperature and sunlight, to organically grow medical cannabis with the lowest possible production costs.
EU medical market estimated to be $64B USD by 2028.
IPOT was up 6.5% today , mc $23.93 M trading over 3X average volume
limited supply being that isracann is the first ever pure-play cannabis firm in Israel - and enormous demand considering the country has the highest highest cannabis use per capita in the world. (~27%)
The underserved domestic market presents significant and immediate opportunity for $IPOT
Israel has all around optimal climatic conditions from humidity, temperature and sunlight, to organically grow medical cannabis with the lowest possible production costs.
EU medical market estimated to be $64B USD by 2028.